E

Glutamic acid

GluENegatively chargedNon-essential

Glutamic acid is aspartate with one more methylene group, and that extra carbon changes what it can reach. It is the most common acidic residue in proteins, the brain’s main excitatory neurotransmitter, and the source of the taste called umami.

Molecular formula
C5H9NO4
Molar mass
147.13 g/mol
Residue mass, average
129.1155 Da
Residue mass, monoisotopic
129.04259 Da
pKa (α-COOH / α-NH₃⁺)
2.19 / 9.67
Side-chain pKa
4.25
Isoelectric point
3.22
CAS number
56-86-0

Structure

O−OαH3N+OO−

The skeletal view begins with the zwitterion at pH 7.

A longer acidic arm

Two methylene groups separate the carboxylate from the backbone, against one for aspartate. The extra reach makes glutamate better at bridging to a distant partner and slightly less prone to attacking its own backbone.

Slightly weaker acid

Its side-chain pKa of 4.25 is higher than aspartate’s 3.65, because the charge sits further from the electron-withdrawing backbone. Both are fully ionised at physiological pH.

Charge and pH

pKa 2.19pKa 4.25pKa 9.67pI 3.22pHNet charge

A low isoelectric point

Like aspartate, glutamate has two acidic groups and one basic, giving an isoelectric point of 3.22. Above pH 5 it is reliably negative.

In a sequence

Glutamate is the standard way to add negative charge and solubility to a peptide without adding much bulk. Poly-glutamate tags are used for exactly that purpose.

Properties

Identity
IUPAC name(2S)-2-aminopentanedioic acid
Three-letter codeGlu
One-letter codeE
ClassNegatively charged
Dietary requirementNon-essential
CAS56-86-0
PubChem CID33032
InChIKeyWHUUTDBJXJRKMK-VKHMYHEASA-N
Physical and chemical
FormulaC5H9NO4
Molar mass147.13 g/mol
Residue mass, average129.1155 Da
Residue mass, monoisotopic129.04259 Da
Side chain−CH₂CH₂COO⁻
pKa, α-carboxyl2.19
pKa, α-amino9.67
pKa, side chain4.25
Isoelectric point3.22
Hydropathy-3.5
Volume ų109

Genetic code and occurrence

Codons

  • GAA
  • GAG

Codons are written as mRNA; U is uracil.

Occurrence
Frequency in proteins6.75%
Number of codons2
Dietary requirementNon-essential

Role in peptides

Pyroglutamate formation

An N-terminal glutamate or glutamine can cyclise to pyroglutamate, blocking the free amino group and subtracting 18 or 17 Da. Some peptides use this deliberately; in others it is an unwanted modification.

Metal binding

Like aspartate, glutamate carboxylates coordinate metal ions, and clusters of the two are the usual architecture of a calcium binding site.

Helix salt bridges

Glutamate paired with lysine four positions along stabilises an alpha helix, a pattern used routinely in designed peptides.

Compounds containing this residue

Published compounds containing this amino acid
CompoundSequenceOccurrencesPositions
BPC-1571 of 152
DSIP1 of 99
Epitalon1 of 42
MOTS-c1 of 165
Pinealon1 of 31
Semax1 of 72

No glutamic acid: KPV, Selank.

Biological role

The main excitatory neurotransmitter

Glutamate carries most of the excitatory signalling in the central nervous system, acting at AMPA, NMDA and kainate receptors. Too much of it outside the cell is toxic, a process called excitotoxicity.

The nitrogen hub

Glutamate sits at the junction of amino acid and carbohydrate metabolism. Transamination moves nitrogen on and off it, which is how the body shuffles amine groups between amino acids.

Umami

Free glutamate is what the umami taste receptor detects, and monosodium glutamate is simply its sodium salt. The glutamate in a tomato and the glutamate in MSG are the same molecule.

Kept out of the brain

Dietary glutamate does not raise brain glutamate appreciably. The blood-brain barrier and the gut both metabolise it heavily, which is central to the safety argument about MSG.

Research evidence

Research evidence for this amino acid
AreaSummaryEvidence
MSG safetyRegulatory reviews have repeatedly found monosodium glutamate acceptable at normal intakes, and controlled challenge studies have not reproduced the symptom cluster once attributed to it. Public perception and the evidence remain some distance apart.Well studied
Excitotoxicity in diseaseGlutamate handling is implicated in stroke, epilepsy and neurodegeneration, and several licensed drugs act on glutamate receptors. This is mechanism and pharmacology rather than nutrition.Established
Glutamate as a supplementSupplemental L-glutamic acid has little human trial literature. Dietary protein supplies large amounts and no deficiency is described.Not studied

These summaries describe research on amino acids and related molecules, not evidence for Aminos products. Aminos products are laboratory research reagents, not supplements or medicines.

Laboratory notes

Pyroglutamate at the N terminus

If a sequence begins with glutamate or glutamine, expect some pyroglutamate to form, particularly at slightly acidic pH and raised temperature. Sequencing by Edman degradation fails on a blocked terminus.

Anion exchange behaviour

Glutamate-rich peptides bind anion exchangers at neutral pH and are eluted with increasing salt.

Poly-glutamate for solubility

Adding a short run of glutamates to a poorly soluble sequence is a standard trick, though it changes the isoelectric point substantially.

Invisible at 280 nm

Glutamate contributes nothing to absorbance at 280 nm.

References

Sources used for the data on this page.

  1. PubChem CID 33032: L-Glutamic acidIdentifiers, formula and physical data.
  2. pKa and pI values for the twenty amino acidsDepartment of Chemistry, University of Calgary.

Reference information only. This page describes the chemistry and biology of an amino acid. Nothing here is medical, nutritional or dosing advice. Aminos compounds are sold strictly for laboratory research use and are not medicines.